Tumor Differentiation

Product view Tumor differentiation

Additional assurance with the characterization of brain tumors.

Evaluation of T1 native, post-CA-T1, T2 & T2-FLAIR sequences (2D or 3D)

Evaluation of T1 native, post-CA-T1, T2 & T2-FLAIR sequences (2D or 3D)

Solid tumor parts are differentiated according to contrast medium uptake. Changes over time are reliably quantified with regard to any progression.

3D supervision through overlays directly in your PACS. Optionally with direct interfaces to your software provider in radiotherapy and neurosurgery (e.g. Brainlab).

Supports you with the diagnostics & monitoring of

Brain tumors:

Differentiation and quantification of tumor core and surrounding marginal oedema for glioblastomas, metastasis and meningiomas.

Peace of mind

mdbrain provides you with an objective second opinion. For more certainty not to miss out on any critical findings.

96%

accuracy in the detection of gliomas

OUR TUMOR REPORT. EVERYTHING AT A GLANCE.

Visualization of the largest detected tumor in all three planes. Including color differentiation of contrast-absorbing parts and marginal edema.

Tabular representation of all characterized tumors that have been detected, including number, volume, and any changes compared to the previous examination if applicable.


Report Tumor differentiation

ARE YOU STILL GUESSING? LET US MEASURE FOR YOU!

Our algorithm has been tested thousands of times and is specialised in giving you additional reassurance in clinical routine.

mdbrain can do even more. Discover the other modules.

mdbrain can do even more. Discover the other modules.

Dementia
Multiple sclerosis
MSA/CBD/PSA

Solutions

*bald verfügbar 

mediaire GmbH

Möckernstrasse 63
10965 Berlin, Germany

P +49 30 286 490 67
F +49 30 286 490 66

© 2022 mediaire GmbH

mediaire GmbH

Möckernstrasse 63
10965 Berlin, Germany

P +49 30 286 490 67
F +49 30 286 490 66

© 2022 mediaire GmbH